Introduction Intra-abdominal infections (IAIs) are a significant, often life-threatening condition affecting millions of patients annually, with treatment responsibility typically distributed
INCACARE
Welcome To
Incacare Live
Incacare Live is an initiative by Concord Biotech to keep you updated with recent advances in critical care. The website shares information regarding incidences of opportunistic fungal infections in patients.
Concord Biotech is a vertically integrated, R&D driven biotechnological powerhouse manufacturing API’s and Finished formulations, offers products across diversified therapeutic segments.
Blog
INTENSIVE CARE UPDATES
Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
Introduction In recent years, invasive fungal infections have emerged as a significant public health threat, particularly among immunocompromised individuals such
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Introduction Invasive fungal diseases (IFD) pose significant morbidity and mortality risks, particularly among immunocompromised patients, but they can also affect
Harnessing of Artificial Intelligence for the Diagnosis and Prevention of Hospital-Acquired Infections: A Systematic Review
Introduction Healthcare-associated infections (HAIs) are a leading global public health concern, representing the most common adverse events in healthcare. Effective
Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review
Introduction Effective treatment of sepsis demands not only the prompt administration of appropriate antimicrobials but also precise dosing to enhance
Introduction Isavuconazole, an advanced generation triazole antifungal, is effective against a wide range of yeasts, molds, and dimorphic fungi. Currently